Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
Jonathan S. Nguyen‐Van‐Tam, Maureen A. O’Leary, Emily T. Martin, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220105-220105
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study
You Li, Durga Kulkarni, Elizabeth Begier, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 4, pp. 1137-1149
Open Access | Times Cited: 62
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain
Andreas Ambrosch, Doris Luber, Frank Klawonn, et al.
Journal of Clinical Virology (2023) Vol. 161, pp. 105399-105399
Open Access | Times Cited: 53
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
Mark H. Rozenbaum, Elizabeth Begier, Samantha K. Kurosky, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 6, pp. 1487-1504
Open Access | Times Cited: 40
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019
Mariana Haeberer, Robin Bruyndonckx, Aleksandra Polkowska-Kramek, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 3, pp. 463-480
Open Access | Times Cited: 23
The disease burden of respiratory syncytial virus in older adults
Sébastien Kenmoe, Harish Nair
Current Opinion in Infectious Diseases (2024)
Open Access | Times Cited: 21
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial
Reynaldo Chandler, Nathali Montenegro, Cecilia Llorach, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 19
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019
Aleksandra Polkowska-Kramek, Elizabeth Begier, Robin Bruyndonckx, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 845-860
Open Access | Times Cited: 14
Respiratory Syncytial Virus Infection in Older Adults: An Update
Franco Alfano, Tommaso Bigoni, Francesco Paolo Caggiano, et al.
Drugs & Aging (2024) Vol. 41, Iss. 6, pp. 487-505
Open Access | Times Cited: 14
Exploring case definitions and the natural history of respiratory syncytial virus in adult outpatients: First-season results of the RESPIRA-50 study
Alexander Domnich, Francesco Lapi, Andrea Orsi, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102653-102653
Open Access | Times Cited: 1
Global burden and trends of respiratory syncytial virus infection across different age groups from 1990 to 2019: A systematic analysis of the Global Burden of Disease 2019 Study
Yuxia Du, Rui Yan, Xiaoyue Wu, et al.
International Journal of Infectious Diseases (2023) Vol. 135, pp. 70-76
Open Access | Times Cited: 32
Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
Mei Grace, Ann Colosia, Sorrel Wolowacz, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 742-759
Open Access | Times Cited: 25
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study
Héloïse Celante, Nadia Oubaya, Slim Fourati, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 943.e1-943.e8
Open Access | Times Cited: 21
Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study
Ann R. Falsey, Tessa Hosman, Arangassery Rosemary Bastian, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 1015-1024
Closed Access | Times Cited: 12
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
Jaya Goswami, Abdullah H Baqui, Pablo Alexis Doreski, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. e996-e1006
Open Access | Times Cited: 12
Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis
Alexander Domnich, Giovanna Elisa Calabrò
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0297608-e0297608
Open Access | Times Cited: 9
Respiratory Syncytial Virus Infections in Recipients of Bone Marrow Transplants: A Systematic Review and Meta-Analysis
Matteo Riccò, Salvatore Parisi, Silvia Corrado, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 2, pp. 317-355
Open Access | Times Cited: 9
From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults
Matteo Boattini, André Almeida, Sara Comini, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 531-531
Open Access | Times Cited: 8
Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022–2023 season
Neli Korsun, Ivelina Trifonova, Iveta Madzharova, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8
Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps
Ricardo de Amorim Corrêa, Francisco Arancibia, Renato de Ávila Kfouri, et al.
Pulmonary Therapy (2024) Vol. 10, Iss. 1, pp. 1-20
Open Access | Times Cited: 7
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol
Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 953-963
Open Access | Times Cited: 6
Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis
Alexander Domnich, Giovanna Elisa Calabrò
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
Daisuke Kurai, Akiko Mizukami, Víctor Preckler, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 303-311
Open Access | Times Cited: 5
Incidence of RSV in Adults: A Comprehensive Review of Observational Studies and Critical Gaps in Information
Benjamin Doty, Parinaz Ghaswalla, Rhonda L. Bohn, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 5
Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65
Robert Buynak, Kevin D. Cannon, David DeAtkine, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 8, pp. 1789-1805
Open Access | Times Cited: 5
Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
Lessandra Michelin, Nancy Bellei, Marcelo Ferreira da Costa Gomes, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top